VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
SRTS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
SRTSSensus Healthcare, Inc.
$2.26$37M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksSRTSCash Flow

Sensus Healthcare, Inc. (SRTS) Cash Flow Statement

12Y historyFree accessUpdated daily

Operational cash flow remains highly volatile, evidenced by a negative 110.7% free cash flow margin in 2026Q1, reflecting the inherent lumpiness of the company's capital equipment sales.

Income StatementBalance SheetCash FlowRatios

SRTS Cash Flow Statement

Annual statement

SRTS Cash Flow Statement

Sensus Healthcare, Inc. (SRTS) cash flow statement — 12-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14
Cash from Operations-11.35M528K-831K-2.15M-1.41M-286K-434.18K-2.11M-8.56M-3.06M-851.02K-1.34M-1.87M
Operating CF Margin %-1.92%-1.99%-8.79%-3.17%-1.06%-4.53%-7.73%-32.41%-14.85%-5.75%-13.04%-32.14%
Operating CF Growth %-606.09%163.54%61.26%-51.91%-393.71%34.13%79.39%75.4%-180.17%-259.17%36.46%28.29%-
Net Income-16.04M-7.72M6.65M485K24.24M4.12M-6.84M-1.7M-2.02M-3.71M-346.45K-237.27K-3.7M
Depreciation & Amortization614K626K432K461K509K613K722K545.72K658.25K387.92K337.58K315.6K272.65K
Stock-Based Compensation286K295K323K328K187K415K0620.92K982.62K405.9K726.38K6.48K6.48K
Deferred Taxes4.24M-1.88M-57K-427K-1.71M00000000
Other Non-Cash Items306K547K378K568K-11.71M705K118.07K728.91K108.53K428.95K3.03M34.5K167.96K
Working Capital Changes-762K8.66M-8.55M-3.56M-12.92M-6.14M5.56M-2.3M-8.29M-568.86K-4.6M-1.46M1.38M
Change in Receivables7.93M13.65M-9.21M6.65M-5.31M-8.43M10.25M-1.22M-8.17M-2.05M-1.03M-1.66M2.12M
Change in Inventory-5.26M-4.63M268K-8.58M-3.19M2.73M-1.43M-1.7M-661.42K118.92K-3.32M-288.39K-327.35K
Change in Payables-1.87M-1.47M2.02M-2.73M799K962K-2.3M-676.56K00000
Cash from Investing-174K-196K-276K-187K14.84M129K7.03M-4.9M-2.64M6.17M-7.85M-196.19K-123.96K
Capital Expenditures-163K-196K-276K-229K-159K-128K-358.55K-400.59K-854.83K-287.59K-286K-196.19K-123.96K
CapEx % of Revenue0.98%0.71%0.66%0.94%0.36%0.47%3.74%1.47%3.23%1.4%1.93%1.91%2.13%
Acquisitions000015M257K002.64B07.85M00
Investments-------------
Other Investing-11K0042K0000-2.64B6.46M-7.85M00
Cash from Financing-5K-305K15K-40K-2.43M-231K210.01K2.62M13.6M1.93M8.68M2.06M-45.42K
Debt Issued (Net)0000-51K-216K266.78K0-2.21M2.21M-422.7K47.7K0
Equity Issued (Net)0-300K67K-27K-3M-15K5602.74M17.25M012.65M2.2M0
Dividends Paid0000000000-2.55M0-45.42K
Share Repurchases0-300K0-27K-3M-15K000-289.29K000
Other Financing-5K-5K-52K-13K622K0-57.33K-118.75K-1.43M-289.29K-994.02K-185.81K0
Net Change in Cash-11.53M27K-1.09M-2.37M11M-388K6.81M-4.38M2.4M5.04M-22.59K526.36K-2.04M
Free Cash Flow-11.51M332K-1.11M-2.37M-1.57M-414K-792.72K-2.51M-9.42M-3.34M-1.14M-1.54M-1.99M
FCF Margin %-69.27%1.21%-2.65%-9.73%-3.53%-1.53%-8.28%-9.2%-35.64%-16.24%-7.68%-14.95%-34.28%
FCF Growth %-631.24%129.99%53.37%-51.11%-279.47%47.77%68.38%73.38%-181.64%-194.12%25.95%22.9%-
FCF per Share-0.700.02-0.07-0.15-0.09-0.03-0.05-0.15-0.67-0.25-0.09-0.14-0.20
FCF Conversion (FCF/Net Income)0.72x-0.07x-0.13x-4.42x-0.06x-0.07x0.06x1.24x4.23x0.82x2.46x5.64x0.50x
Interest Paid00002K00000000
Taxes Paid0980K2.58M1.44M4.57M00000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetHealthy
Cash FlowBurning
Top Statement Risk

Reimbursement and sales volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Lacks Cash Support

According to recent financial disclosures, the relationship between net income and operating cash flow for SRTS remains highly volatile, with the OCF/NI ratio fluctuating wildly between 1.43 and -3.60, suggesting that reported earnings are currently disconnected from the company's actual ability to generate liquid cash.

The frequent divergence between net income and operating cash flow indicates that accrual-based accounting adjustments are significantly masking the underlying cash burn. Investors should monitor whether this volatility stems from aggressive revenue recognition timing or erratic changes in accounts receivable, as the lack of consistent cash conversion complicates the assessment of true operational health.

FCF Margins Reflect Operational Instability

As reported in quarterly statements, Sensus Healthcare's free cash flow trajectory has been erratic, swinging from a positive 42.2% margin in 2025Q2 to a negative 110.7% margin in 2026Q1, which highlights the extreme sensitivity of the company's cash generation to its lumpy capital equipment sales cycle.

The inability to maintain positive free cash flow during periods of revenue contraction suggests that the company's fixed cost structure is not sufficiently flexible to adapt to lower demand. This trend warrants further investigation into whether the current cash burn is a temporary byproduct of strategic investment or a structural failure to achieve break-even scale.

Working Capital Swings Drive Liquidity

Based on the company's reported cash flow statements, working capital changes have been the primary driver of quarterly cash flow volatility, with swings as large as $11.6M in 2024Q1, indicating that the company's cash position is highly dependent on the timing of customer payments and inventory management.

The significant reliance on working capital fluctuations to bridge the gap between operating losses and cash availability suggests that the company's core business is not yet self-sustaining. Analysts should scrutinize whether these working capital movements represent genuine operational efficiency or merely the deferral of cash outflows that may eventually pressure the balance sheet.

Capital Allocation Remains Defensive Posture

As noted in recent filings, Sensus Healthcare has maintained a conservative capital deployment strategy, avoiding significant debt or aggressive buybacks, with the exception of a $300K share repurchase in 2025Q1, which appears to be a minor effort to support equity value amidst declining operational performance.

The company's decision to preserve its cash cushion rather than aggressively reinvesting in growth or returning capital to shareholders suggests a management team focused on survival in a challenging reimbursement environment. This defensive stance may be prudent, but it also raises questions about the company's long-term strategy for reigniting growth in its core dermatology business.

SRTS — Frequently Asked Questions

Quick answers to the most common questions about buying SRTS stock.

How much cash does Sensus Healthcare, Inc. (SRTS) generate from operations?

Sensus Healthcare, Inc. (SRTS) generated $0.5M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Sensus Healthcare, Inc.'s free cash flow?

Sensus Healthcare, Inc. (SRTS) generated $0.3M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Sensus Healthcare, Inc.'s capital expenditure (CapEx)?

Sensus Healthcare, Inc. (SRTS) spent $0.2M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Sensus Healthcare, Inc. distribute cash to shareholders?

In 2025, Sensus Healthcare, Inc. (SRTS) spent $0.3M on share repurchases. This shows the company's commitment to returning capital to its equity investors.